Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 38134948

Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2024 Feb
First author
Shitara K

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Transl Gastroenterol Hepatol. 2024 Oct 23;10:18. doi: 10.21037/tgh-24-57.
    note
    Source null
    related pmid
    39944585
    relationship
    Comment in

Authors and identifiers

  1. name
    Shitara K
    type
    Author
  2. name
    Rha SY
    type
    Author
  3. name
    Wyrwicz LS
    type
    Author
  4. name
    Oshima T
    type
    Author
  5. name
    Karaseva N
    type
    Author
  6. name
    Osipov M
    type
    Author
  7. name
    Yasui H
    type
    Author
  8. name
    Yabusaki H
    type
    Author
  9. name
    Afanasyev S
    type
    Author
  10. name
    Park YK
    type
    Author
  11. name
    Al-Batran SE
    type
    Author
  12. name
    Yoshikawa T
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Shitara K
    type
    Author
  2. name
    Rha SY
    type
    Author
  3. name
    Wyrwicz LS
    type
    Author
  4. name
    Oshima T
    type
    Author
  5. name
    Karaseva N
    type
    Author
  6. name
    Osipov M
    type
    Author
  7. name
    Yasui H
    type
    Author
  8. name
    Yabusaki H
    type
    Author
  9. name
    Afanasyev S
    type
    Author
  10. name
    Park YK
    type
    Author
  11. name
    Al-Batran SE
    type
    Author
  12. name
    Yoshikawa T
    type
    Author
bibliography ids
  1. nci-bib-e689aeb99d311883f8419d84
book metadata
content sha256
3387898dcd866fab0efa5b0f2a03c2359caed6de2941295c5aa7ff80ff837f6e
document type
citation
dois
  1. 10.1016/S1470-2045(23)00541-7
electronic publication date
display
2023 Dec 19
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:38134948
immutable id
pubmed:38134948@3387898dcd866fab0efa5b0f2a03c2359caed6de2941295c5aa7ff80ff837f6e
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
2
name
The Lancet. Oncology
nlm unique id
100957246
pages
212-224
volume
25
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Transl Gastroenterol Hepatol. 2024 Oct 23;10:18. doi: 10.21037/tgh-24-57.
    note
    Source null
    related pmid
    39944585
    relationship
    Comment in
outcomes validated
false
pmid
38134948
provenance
batch id
6d213eecf21b6b7867cb
provider
NCBI PubMed ESummary
record sha256
9bd30580c6279730ebb2ad0195e6d3717ad865f2f1a4839ad5c109d3f0b25e89
response sha256
684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
retrieved at
2026-09-09T23:48:19.049083+00:00
publication date
display
2024 Feb
precision
month
year
2024
publication types
  1. Randomized Controlled Trial
  2. Multicenter Study
  3. Clinical Trial, Phase III
  4. Journal Article
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/38134948/
title
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study.

Preserved source evidence · Not medical advice